World's Best Scientists 2026 revealed!
Michael T. Nurmohamed

Michael T. Nurmohamed

D-Index & Metrics

Medicine

D-Index
81
Citations
27827
World Ranking
16505
National Ranking
626

Overview

Michael T. Nurmohamed is affiliated with the University of Amsterdam in the Netherlands. Their research primarily focuses on medicine, with a strong emphasis on rheumatology. Additional subfields of their work include immunology, hematology, infectious diseases, and genetics.

The scientist has contributed extensively to key topics within their field, including:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Autoimmune and Inflammatory Disorders Research
  • Spondyloarthritis Studies and Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Biosimilars and Bioanalytical Methods
  • Monoclonal and Polyclonal Antibodies Research

Their frequently published venues showcase their presence in specialty journals related to rheumatology and inflammation. These venues include:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • RMD Open
  • The Lancet Rheumatology
  • Scandinavian Journal of Rheumatology

Michael T. Nurmohamed's collaborations feature frequent coauthors such as Ronald van Vollenhoven, Gertjan Wolbink, Sander W. Tas, Maarten Boers, and Merete Lund Hetland, indicating a well-established network within their research community.

Recent published papers highlight a focus on cardiovascular risk and autoimmune disease management. Notable works include:

  • EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome (2022) published in Annals of the Rheumatic Diseases
  • Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout (2020) published in The Lancet Rheumatology
  • Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies (2021) published in The Lancet Rheumatology
  • Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial (2020) published in BMJ
  • Cardiovascular effects of approved drugs for rheumatoid arthritis (2021) published in Nature Reviews Rheumatology

Best Publications

  • EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

    M J Peters;D P M Symmons;D McCarey;B A Dijkmans

  • EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

    R. Agca;S. C. Heslinga;S. Rollefstad;M. Heslinga

  • Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up.

    Geertje M. Bartelds;Charlotte L. M. Krieckaert;Michael T. Nurmohamed;Pauline A. van Schouwenburg

  • Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

    Geertje M Bartelds;Carla A Wijbrandts;Michael T Nurmohamed;Steven Stapel

  • 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis

    Anne-Kathrin Rausch Osthoff;Karin Niedermann;Jürgen Braun;Jo Adams

  • Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

    Gerrit Jan Wolbink;Marijn Vis;Willem Lems;Alexandre E. Voskuyl

  • Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation

    V P van Halm;M J L Peters;A E Voskuyl;M Boers

  • Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.

    Mike J. Peters;Irene E. van der Horst-Bruinsma;Ben A. Dijkmans;Michael T. Nurmohamed

  • Does Rheumatoid Arthritis Equal Diabetes Mellitus as an Independent Risk Factor for Cardiovascular Disease? A Prospective Study

    Mike J. L. Peters;Vokko P. van Halm;Alexandre E. Voskuyl;Yvo M. Smulders

  • Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus.

    Inge A. M. van den Oever;Hennie G. Raterman;Mike T. Nurmohamed;Suat Simsek

  • Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

    Désirée van der Heijde;James Cheng-Chung Wei;Maxime Dougados;Philip Mease

  • Influence of Glucocorticoids and Disease Activity on Total and High Density Lipoprotein Cholesterol in Patients With Rheumatoid Arthritis

    M Boers;M T Nurmohamed;C J A Doelman;L R Lard

  • Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

    Ernest Choy;Kandeepan Ganeshalingam;Anne Grete Semb;Zoltán Szekanecz

  • Cardiovascular comorbidity in rheumatic diseases

    Michael T. Nurmohamed;Maaike Heslinga;George D. Kitas

  • Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study

    Vokko P van Halm;Michael T Nurmohamed;Jos W R Twisk;Ben A C Dijkmans

  • Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review

    Anna Jamnitski;Deborah Symmons;Mike J L Peters;Naveed Sattar

  • Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study

    Geertje M Bartelds;Carla A Wijbrandts;Michael T Nurmohamed;Steven O Stapel

  • Lipids and inflammation - Serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis

    V P van Halm;M M J Nielen;M T Nurmohamed;D van Schaardenburg

  • Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner

    Charlotte L Krieckaert;Michael T Nurmohamed;Gerrit Jan Wolbink

  • Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

    G.J. Wolbink;A.E. Voskuyl;W.F. Lems;E. de Groot

Frequent Co-Authors

Willem F. Lems
Willem F. Lems Vrije Universiteit Amsterdam
Maarten Boers
Maarten Boers Vrije Universiteit Amsterdam
Gertjan Wolbink
Gertjan Wolbink University of Amsterdam
Ben A. C. Dijkmans
Ben A. C. Dijkmans Amsterdam UMC
Theo Rispens
Theo Rispens University of Amsterdam
Jos W. R. Twisk
Jos W. R. Twisk Amsterdam UMC
Laure Gossec
Laure Gossec Sorbonne University
Elisa Gremese
Elisa Gremese Catholic University of the Sacred Heart
Karel Pavelka
Karel Pavelka Charles University
Josef S. Smolen
Josef S. Smolen Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in medicine? There are a variety of online degrees and career pathways that support both clinical and non-clinical roles in healthcare. For registered nurses aiming to become family nurse practitioners, asn to fnp bridge programs offer a fast track to advanced practice roles.

Nutrition is another high-impact field with strong overlaps in medicine. Students can explore the best online nutrition degree programs to specialize in dietetics and wellness.

Healthcare administration is essential for those interested in leadership rather than direct patient care. Accredited online mha programs equip graduates to manage hospitals and healthcare organizations efficiently.

For those already holding an RN, options like rn bsn online programs no clinicals allow nurses to advance their qualifications without traditional clinical requirements.

Whether your interests are clinical, administrative, or nutritional, these flexible online programs open doors for career growth and specialization in the medical field.

Best Scientists Citing Michael T. Nurmohamed

Trending Scientists